Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Quality Control Guidelines Proposed for Genomics Studies

Published: Friday, April 25, 2014
Last Updated: Friday, April 25, 2014
Bookmark and Share
Guidelines for researchers studying the effects of rare genetic variants.

Sequencing an entire human genome is faster and cheaper than ever before, leading to an explosion of studies comparing the genomes of people with and without a given disease. Often clinicians and researchers studying genetic contributions to a certain disease encounter variations that appear to be responsible, only to find other people with the same mutation who don’t have the disease or who are affected to a lesser degree.

How do doctors pinpoint the genetic changes that really cause disease? An open-access policy paper published Wednesday in Nature proposes guidelines for researchers studying the effects of rare genetic variants. The recommendations focus on several key areas, such as study design, gene- and variant-level implication, databases and implications for diagnosis.

Co-author Chris Gunter, PhD, associate director of research at Marcus Autism Center and associate professor of pediatrics at Emory, is one of the organizers of the 2012 workshop of leading genomics researchers, sponsored by the National Human Genome Research Institute, that led to the paper.

“Several of us had noticed that studies were coming out with wrong conclusions about the relationship between a specific sequence and disease, and we were extremely concerned that this would translate into inappropriate clinical decisions,” she says.

Potentially, based on flawed results, physicians could order additional testing or treatments that are not truly supported by a link between a genetic variant and disease, and this paper could help prevent such inappropriate decisions, Gunter says.

The group of 27 researchers proposes two steps for claiming that a genetic variation causes disease: detailed statistical analysis followed by an assessment of evidence from all sources supporting a role for the variant in that specific disease or condition. In addition, they highlight priorities for research and infrastructure development, including added incentives for researchers to share genetic and clinical data.

One case cited in the paper relates to autism. Researchers found four independent variations in a gene called TTN when they compared genomes between individuals with and without autism. However, the TTN gene encodes a muscle protein (titin) that is the largest known; variations are simply more likely to be found within its boundaries compared to those of other genes. Without applying the proper statistical corrections, researchers may have falsely concluded that TTN was worthy of further investigation in autism studies.

The authors note that many DNA variants “may suggest a potentially convincing story about how the variant may influence the trait,” but few will actually have causal effects. Thus, using evidence-based guidelines such as the ones in the Nature paper will be crucial.

“We believe that these guidelines will be particularly useful to scientists and clinicians in other areas who want to do human genomic studies, and need a defined starting point for investigating genetic effects, “ Gunter says.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nanoparticles Deliver Anticancer Cluster Bombs
Researchers at Emory have devised a triple-stage "cluster bomb" system for delivering the chemotherapy drug cisplatin, via tiny nanoparticles designed to break up when they reach a tumor.
Saturday, April 16, 2016
Mixed-Strain Malaria Influences Drug Resistance
Scientists have documented for the first time how competition among different malaria parasite strains in human hosts could influence the spread of drug resistance.
Thursday, March 24, 2016
DTRA Awards $9.7M Contract for Drug Development
The Defense Threat Reduction Agency (DTRA) has awarded Emory University a $9.7M contract to develop drugs to treat infections caused by emerging and man-made viral threats. Under the contract, the DTRA funds will be used to advance the development of the lead drug candidate.
Thursday, February 04, 2016
Predicting Flu Vaccine Efficacy
Researchers reveal novel molecular signatures that could be used to predict which individuals are most likely to respond positively to vaccination.
Thursday, December 17, 2015
How White Blood Cells Limit Muscle Regeneration
Researchers have identified a protein produced by white blood cells that puts the brakes on muscle repair after injury.
Monday, August 10, 2015
First Look At Hospitalized Ebola Survivors' Immune Cells Could Guide Vaccine Design
Emory and CDC researchers have been examining immune cells obtained from four patients treated at Emory University Hospital in 2014.
Wednesday, March 11, 2015
One-minute Point-of-Care Anemia Test Shows Promise in New Study
Test produces results in about 60 seconds and requires no electrical power.
Tuesday, September 16, 2014
Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice
Study demonstrate a dependency on gut bacteria for strong immune responses to the seasonal flu and inactivated polio vaccines.
Tuesday, September 16, 2014
Steering Stem Cells with Magnets
Magnets could be a tool for directing stem cells’ healing powers to treat conditions such as heart disease or vascular disease.
Thursday, July 18, 2013
Briefing Explores Associations between Air Pollution and Health Outcomes
Health risks associated with high levels of air pollution may vary between neighborhoods across large urban populations.
Monday, February 25, 2013
X-ray Research at Diamond Paves Way for Lassa Fever Vaccine and Drug Development
Research shows how the Lassa virus remains invisible to the human defence system and causes thousands of deaths each year.
Friday, November 19, 2010
Emory Study Yields Clue to How Stem Cells Form
Study shows some of the first direct evidence of a process required for epigenetic reprogramming between generations.
Tuesday, April 21, 2009
Researchers Discover Strategy for Predicting the Immunity of Vaccines
Emory study reveals how a highly successful vaccine triggers robust immune responses.
Monday, November 24, 2008
NIH Awards Emory $3.6 Million for Schizophrenia Gene Research
Emory University's School of Medicine has received a $3.6M grant form NIH to study a human genetic variation linked to schizophrenia.
Tuesday, May 22, 2007
Scientists Determine How Tumor Gene Controls Growth
Researchers have uncovered details about how Tsg 101 Gene causes cells to overgrow.
Monday, November 07, 2005
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!